News this week (8). Vaccinations for Johnson & Johnson resumed in South Africa, there were no schools in Madagascar, chaos in South Sudan and Malawi, and Sputnik V was produced in Egypt.
Resuming Johnson & Johnson vaccination in South Africa
South Africa announced on Thursday, April 22, that it will begin to administer the Johnson & Johnson vaccine to its health workers again next week. The procedure was suspended due to 6 cases of potential risk of blood clotting reported in the United States.
The South African authorities finally confirmed that among the estimated 290,000 medical staff who have received the vaccine, no such serious incident has been reported. Health experts in this country expressed satisfaction with this decision. The expert recorded pollution records across the African continent (more than 1.5 million cases and nearly 54,000 deaths), and its vaccination efforts have suffered many setbacks in recent months. Therefore, in February, the health authorities abandoned the use of the AstraZeneca vaccine, which was considered ineffective against the so-called “South African” virus mutation.
The Johnson & Johnson vaccine is currently being used in a study to provide 1.2 million medical staff across the country with an opportunity for early immunization. The second phase of the vaccination plan, especially for people over 60, will begin on May 17. So far, South Africa has ordered 31 million doses of Johnson & Johnson vaccine and 30 million doses of Pfizer. It is estimated that the international Covax plan will provide 1.3 million euros.
Students in Madagascar are deprived of tuition fees